LUTEOLIN SUPPRESSES SQUAMOUS DIFFERENTIATION OF BLADDER CANCER AND CANCER GROWTH VIA REGULATION OF MAMMALIAN TARGET OF RAPAMYCIN PATHWAY

被引：0
|
作者：
Iida, Keitaro
Naiki, Taku
Naiki-Ito, Aya
Nagai, Takashi
Nozaki, Satoshi
Etani, Toshiki
Ando, Ryosuke
Kawai, Noriyasu
Yasui, Takahiro
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP01-09
引用
收藏
页码：E5 / E5
页数：1
相关论文
共 50 条
  • [1] LUTEOLIN SUPPRESSES SQUAMOUS DIFFERENTIATION OF BLADDER CANCER AND CANCER GROWTH VIA REGULATION OF MAMMALIAN TARGET OF RAPAMYCIN PATHWAY
    Iida, Keitaro
    Naiki-Ito, Aya
    Nagai, Takashi
    Nozaki, Satoshi
    Etani, Toshiki
    Naiki, Taku
    Kawai, Noriyasu
    Takahashi, Satoru
    Yasui, Takahiro
    JOURNAL OF UROLOGY, 2021, 206 : E656 - E657
  • [2] Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway
    Iida, Keitaro
    Naiki, Taku
    Naiki-Ito, Aya
    Suzuki, Shugo
    Kato, Hiroyuki
    Nozaki, Satoshi
    Nagai, Takashi
    Etani, Toshiki
    Nagayasu, Yuko
    Ando, Ryosuke
    Kawai, Noriyasu
    Yasui, Takahiro
    Takahashi, Satoru
    CANCER SCIENCE, 2020, 111 (04) : 1165 - 1179
  • [3] The mammalian target of rapamycin pathway as a potential target for cancer chemoprevention
    Kopelovich, Levy
    Fay, Judith R.
    Sigman, Caroline C.
    Crowell, James A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (07) : 1330 - 1340
  • [4] New inhibitors of the mammalian target of rapamycin signaling pathway for cancer
    Albert, Sebastien
    Serova, Maria
    Dreyer, Chantal
    Sablin, Marie-Paule
    Faivre, Sandrine
    Raymond, Eric
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (08) : 919 - 930
  • [5] Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer
    Mansure, Jose
    Nassim, Roland
    Rocha, Joice
    Scarlata, Eleonora
    Chevalier, Simone
    Kassouf, Wassim
    CANCER RESEARCH, 2009, 69
  • [6] Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer
    Mansure, Jose J.
    Nassim, Roland
    Chevalier, Simone
    Rocha, Joice
    Scarlata, Eleonora
    Kassouf, Wassim
    CANCER BIOLOGY & THERAPY, 2009, 8 (24) : 2339 - 2347
  • [7] Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer
    Albert, Jeffrey M.
    Kim, Kwang Woon
    Cao, Carolyn
    Lu, Bo
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (05) : 1183 - 1189
  • [8] Regulation of the mammalian target of rapamycin signaling by grape polyphenols in breast cancer
    Rivera, Amilcar Rivera
    Pichardo, Linnette Castillo
    Dharmawardhane, Suranganie
    FASEB JOURNAL, 2014, 28 (01):
  • [9] Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy
    Huang, Xiaoxing
    Zhang, Hailong
    Yang, Jun
    Wu, Jingfan
    McMahon, John
    Lin, Yufan
    Cao, Zhonglian
    Gruenthal, Michael
    Huang, Yunfei
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 193 - 199
  • [10] Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer
    Wu, Chengyu
    Huang, Jiaoti
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (06) : 3571 - 3583
12345